Submitted by Anonymous (not verified) on 15 April 2026 - 15:44
Human medicines European public assessment report (EPAR): Kygevvi, doxecitine,doxribtimine, Date of authorisation: 26/03/2026, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kygevvi, doxecitine,doxribtimine, Date of authorisation: 26/03/2026, Status: Authorised